HPLC determination of bendrofluazide in capsules

A.R. Barnes, S. Nash

Research output: Contribution to journalArticlepeer-review


A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

Original languageEnglish
Pages (from-to)231-234
Number of pages4
JournalInternational Journal of Pharmaceutics
Issue number1-3
Publication statusPublished - 21 Jun 1993


  • assay
  • bendrofluazide
  • capsules
  • HPLC
  • tablets


Dive into the research topics of 'HPLC determination of bendrofluazide in capsules'. Together they form a unique fingerprint.

Cite this